Back
Speaker illustration

Doctor Anna Damlin

Karolinska Institute, Stockholm (Sweden)

Member of:

European Society of Cardiology

Presentations

Navigating hypertrophic cardiomyopathy echo imaging with cardiac myosin inhibitors

Event: ESC Congress 2024

Topic: Hypertrophic Cardiomyopathy

Session: Navigating hypertrophic cardiomyopathy echo imaging with cardiac myosin inhibitors

Access
Like
Thumbnail

Navigating hypertrophic cardiomyopathy (HCM) echo imaging with cardiac myosin inhibitors

Event: ESC Congress 2024

Topic: Hypertrophic Cardiomyopathy

Session: Navigating hypertrophic cardiomyopathy (HCM) echocardiographic imaging with cardiac myosin inhibitors

Access
Like
Thumbnail

Sex-based differences in anatomical and hemodynamic parameters and outcomes in patients with hypertrophic cardiomyopathy undergoing alcohol septal ablation

Event: ESC Congress 2024

Topic: Epidemiology, Prognosis, Outcome

Session: Hypertrophic and other cardiomyopathies: miscellaneous findings

Access
Like
Thumbnail

Suggested modification of the recommendations for echocardiography in patients with clinical suspicion of infective endocarditis

Event: EuroEcho 2021

Topic: Transoesophageal Echocardiography (TOE)

Session: e-posters session - Echocardiography

Access
Like
Thumbnail

Relationships between bacteria and echocardiographic manifestations in infective endocarditis - data from the Swedish endocarditis registry

Event: ESC Congress 2019

Topic: Diagnostic Methods

Session: Endocarditis: pathophysiology, clinical features and management

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources